The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
Open accessAbstract
TGFbeta1 has been implicated in cell cycle control and carcinogenesis. To address the exact function of TGFbeta1 in skin carcinogenesis in vivo, mice with TGFbeta1 expression targeted to keratinocytes were subjected to long-term chemical carcinogenesis treatment. TGFbeta1 showed biphasic action during multistage skin carcinogenesis, acting early as a tumor suppressor but later enhancing the malignant phenotype. The transgenics were more resistant to induction of benign skin tumors than controls, but the malignant conversion rate was vastly increased. There was also a higher incidence of spindle cell carcinomas, which expressed high levels of endogenous TGFbeta3, suggesting that TGFbeta1 elicits an epithelial-mesenchymal transition in vivo and that TGFbeta3 might be involved in maintenance of the spindle cell phenotype. The action of TGFbeta1 in enhancing malignant progression may mimic its proposed function in modulating epithelial cell plasticity during embryonic development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, TGF-β3 is clearly expressed by stromal CAFs and mesenchymal tumor cells41,70,247”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [41]
Citations
Cites
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U., Liotta, L. A., Falanga, V., & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,867
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Kaartinen, V., Voncken, J. W., Shuler, C. F., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,042
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.2021 · Cited by 939
Transforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., & Berger, W. H. (1987) · PubMed · Cited by 898
Kimelman, D., & Kirschner, M. W. (1987) · Cell · doi:10.1016/0092-8674(87)90110-3 · Cited by 872
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3210-0_8 · Cited by 869
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 744
Ansari, B., Coates, P. J., Greenstein, B., & Hall, P. A. (1993) · The Journal of Pathology · doi:10.1002/path.1711700102 · Cited by 578
Research works printed but not linked: 11
- Arteaga, 1990, Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies, Cell Growth Differ., 1, 367
- Caulin, 1995, Chronic exposure of cultured transfected mouse epidermal cells to TGFβ1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype, Cell Growth Differ., 6, 1027
- Cui, W., and Akhurst, R.J. (1996). Transforming growth factors β: biochemistry and biology in vitro and in vivo. In Growth Factors and Cytokines in Health and Disease, C. Bondy and D. LeRoith, eds. (Greenwich, Connecticut: JAI Press), in press.
- Cui, 1994, Lack of TGFβ1 expression in benign skin tumours of p53 null mice is prognostic for a high risk of malignant conversion, Cancer Res., 54, 5831
- Dlugosz, 1995, Autocrine transforming growth factor α is dispensible for v-ras-Ha-induced epidermal neoplasia, Cancer Res., 55, 1883
- Fowlis, 1992, Discordant TGFβ1 RNA and protein localisations during chemical carcinogenesis of the skin, Cell Growth Differ., 3, 81
- Fowlis, 1996, Altered epidermal growth control in vivo in transgenic mice expressing TGFβ1 from an inducible keratin gene promoter, Cell Growth Differ., 7, 679
- Gomella, 1989, Expression of transforming growth factor α in normal adult kidney and enhanced expression of transforming growth factors α and β in renal cell carcinoma, Cancer Res., 49, 6972
- Manning, 1991, Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β), Oncogene, 6, 1471
- Steiner, 1992, Transforming growth factor-β-1 overproduction in prostate cancer, Mol. Endocrinol., 6, 15
- Tennenbaum, 1992, Extracellular matrix receptors and mouse skin carcinogenesis, Cancer Res., 52, 2966
Cited by
Sorted by citations
Items 201–300 of 623
Recent advances in cancer research: mouse models of tumorigenesis
Herzig, M., & Christofori, G. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00039-2 · Cited by 89
Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4
Morén, A., Itoh, S., Moustakas, A., ten Dijke, P., & Heldin, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203798 · Cited by 90
Cancer cells remodel themselves and vasculature to overcome the endothelial barrier
Shenoy, A. K., & Lu, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.031 · Cited by 89
Stevenson, J. P., Kindler, H. L., Papasavvas, E., Sun, J., Jacobs-Small, M., Hull, J., Schwed, D., Ranganathan, A., Newick, K., Heitjan, D. F., et al. (2013) · OncoImmunology · doi:10.4161/onci.26218 · Cited by 85
Ellenrieder, V., Buck, A., Harth, A. J., Jungert, K., Buchholz, M., Adler, G., Urrutia, R. A., & Gress, T. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.018 · Cited by 86
Dhillon, A. S., & Tulchinsky, E. M. (2014) · Oncogene · doi:10.1038/onc.2014.374 · Cited by 85
Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis
To, M. D., Rosario, R. D., Westcott, P. M. K., Banta, K. L., & Balmain, A. (2012) · Oncogene · doi:10.1038/onc.2012.404 · Cited by 82
Self-citationDanielpour, D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.2.169 · Cited by 84
Connolly, E. C., Saunier, E. F., Quigley, D., Luu, M. T., De Sapio, A., Hann, B., Yingling, J. M., & Akhurst, R. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2941 · Cited by 82
Self-citationTGFβ signaling pathways in human health and disease
Chen, P., Qin, L., & Simons, M. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1113061 · Cited by 89
Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis
Li, A. G., Lu, S., Zhang, M., Deng, C., & Wang, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1331 · Cited by 81
Expression of αvβ6integrin in oral leukoplakia
Hamidi, S., Salo, T. A., Kainulainen, T., Epstein, J. B., Lerner, K., & Langrish, V. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1130 · Cited by 81
He, W., Cao, T., Smith, D. A., Myers, T. E., & Wang, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204117 · Cited by 80
Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis
Dalla, E., Papanicolaou, M., Park, M. D., Barth, N. D., Hou, R., Segura-Villalobos, D., Salazar, L. E. V., Sun, D., Forrest, A. R. R., Casanova-Acebes, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.016 · Cited by 92
Smad7 induces hepatic metastasis in colorectal cancer
Halder, S., Rachakonda, G., Deane, N. G., & Datta, P. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604562 · Cited by 83
Reichelt, J., Fürstenberger, G., & Magin, T. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23426.x · Cited by 83
Sokol, J. P., Neil, J. R., Schiemann, B. J., & Schiemann, W. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1312 · Cited by 80
Weber, F., Byrne, S. N., Le, S., Brown, D. A., Breit, S. N., Scolyer, R. A., & Halliday, G. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0652-3 · Cited by 83
Role of Transforming Growth Factor-β In Cancer Progression
Galliher, A. J., Neil, J. R., & Schiemann, W. P. (2006) · Future Oncology · doi:10.2217/14796694.2.6.743 · Cited by 80
Kaklamani, V., Baddi, L., Liu, J., Rosman, D. S., Phukan, S., Bradley, C. T., Hegarty, C., McDaniel, B., Rademaker, A., Oddoux, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2961 · Cited by 80
Shao, J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.185 · Cited by 80
Hamamoto, T., Beppu, H., Okada, H., Kawabata, M., Kitamura, T., Miyazono, K., & Kato, M. (2002) · PubMed · Cited by 79
Transforming Growth Factor-β: Biology and Clinical Relevance
Kim, I. Y., Kim, M. M., & Kim, S. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.1.001 · Cited by 79
Go, C., Li, P., & Wang, X. (1999) · PubMed · Cited by 79
Tonn, J., Kerkau, S., Hanke, A., Bouterfa, H., Mueller, J. G., Wagner, S., Vince, G. H., & Roosen, K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990301)80:5 · Cited by 142
Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis
Beaudry, V. G., Jiang, D., Dusek, R. L., Park, E. J., Knezevich, S. R., Ridd, K., Vogel, H. S., Bastian, B. C., & Attardi, L. D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001168 · Cited by 80
Bommireddy, R., Saxena, V., Ormsby, I., Yin, M., Boivin, G. P., Babcock, G. F., Singh, R. R., & Doetschman, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4612 · Cited by 76
Iglesias, M., Frontelo, P., Gamallo, C., & Quintanilla, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203764 · Cited by 76
Lindley, L. E., & Briegel, K. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.138 · Cited by 76
Transcription factor Dlx2 protects from TGFβ‐induced cell‐cycle arrest and apoptosis
Yilmaz, M., Maaß, D., Tiwari, N., Waldmeier, L., Schmidt, P., Lehembre, F., & Christofori, G. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.319 · Cited by 76
Smad4-independent regulation of p21/WAF1 by transforming growth factor-β
Ijichi, H., Otsuka, M., Tateishi, K., Ikenoue, T., Kawakami, T., Kanai, F., Arakawa, Y., Seki, N., Shimizu, K., Miyazono, K., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207222 · Cited by 78
Fujimoto, K., Sheng, H., Shao, J., & Beauchamp, R. D. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5229 · Cited by 75
Won, J., Kim, H., Park, E. J., Hong, Y., Kim, S., & Yun, Y. (1999) · PubMed · Cited by 76
Snail controls differentiation of hepatocytes by repressing HNF4α expression
Cicchini, C., Filippini, D., Coen, S., Marchetti, A., Cavallari, C., Laudadio, I., Spagnoli, F. M., Alonzi, T., & Tripodi, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20730 · Cited by 75
Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model
Wang, Z., Birch, C. M., Sagotsky, J., & Deisboeck, T. S. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp416 · Cited by 74
Sialylation of vasorin by ST3Gal1 facilitates TGF‐β1‐mediated tumor angiogenesis and progression
Yeo, H. L., Fan, T.-C., Lin, R., Yu, J., Liao, G., Chen, E. S.-W., Ho, M., Lin, W., Chen, K., Chen, C., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31891 · Cited by 75
Languino, L. R., Singh, A., di Prisco, M., Inman, G. J., Luginbuhl, A., Curry, J., & South, A. P. (2016) · PubMed Central · Cited by 74
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
Tan, N. S., Vázquez‐Carrera, M., Montagner, A., Sng, M. K., Guillou, H., & Wahli, W. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.001 · Cited by 75
Jechlinger, M., Grünert, S., & Beug, H. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1024090116451 · Cited by 78
Chen, T., Wu, Y., Wells, R. G., Rimm, D. L., McNiff, J. M., Leffell, D. J., & Reiß, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1381 · Cited by 74
Gupta, R. A., Sarraf, P., Brockman, J. A., Shappell, S. B., Raftery, L. A., Willson, T. M., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208076200 · Cited by 73
Kim, J., & Kim, S. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074342 · Cited by 72
Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma
Wu, F., Weigel, K. J., Zhou, H., & Wang, X. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx127 · Cited by 72
Yu, H., Shen, Y., Hong, J., XIA, Q., ZHOU, F., & Liu, X. (2015) · Neoplasma · doi:10.4149/neo_2015_002 · Cited by 71
Kuo, Y.-C., Su, C., Liu, C., Chen, T.-H., Chen, C., & Wang, H. (2009) · International Journal of Cancer · doi:10.1002/ijc.24263 · Cited by 71
Blanco, D., Vicent, S., Elizegi, E., Pino, I., Fraga, M. F., Esteller, M., Saffiotti, U., Lecanda, F., & Montuenga, L. M. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700129 · Cited by 70
Thomas‐Tikhonenko, A., Viard, I., Dews, M., Wehrli, P., Sevignani, C., Yu, D., Ricci, S., El‐Deiry, W. S., Aronow, B. J., Kaya, G., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1953 · Cited by 70
Voorzanger‐Rousselot, N., Juillet, F., Mareau, E., Zimmermann, J., Kalebic, T., & Garnero, P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603285 · Cited by 71
POTENTIAL HEALTH RISKS OF RADIOFREQUENCY FIELDS FROM WIRELESS TELECOMMUNICATION DEVICES
Daniel Krewski, C. V. B. (2001) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400121067 · Cited by 69
Biswas, S., Criswell, T. L., Wang, S. E., & Arteaga, C. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0952 · Cited by 68
A Gain of Function TGFB1 Polymorphism May Be Associated With Late Stage Prostate Cancer
Toland, A. E., Chan, J. M., Yuan, J., Balmain, A., & Ma, J. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.759.13.5 · Cited by 67
Self-citationLiu, X., Lee, J., Cooley, M. A., Bhogte, E., Hartley, S., & Glick, A. B. (2003) · PubMed · Cited by 67
Hougaard, S., Nørgaard, P. H., Abrahamsen, N., Moses, H. L., Spang‐Thomsen, M., & Poulsen, H. S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690161 · Cited by 67
Li, Q., Karam, S. M., Coerver, K. A., Matzuk, M. M., & Gordon, J. I. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.2.0060 · Cited by 67
Imai, K., Minamiya, Y., Koyota, S., Ito, M., Saito, H., Sato, Y., Motoyama, S., Sugiyama, T., & Ogawa, J. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-3 · Cited by 66
Wilkins-Port, C. E., Ye, Q., Mazurkiewicz, J. E., & Higgins, P. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0043 · Cited by 64
TGF-β signaling in cancer — a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82259-5 · Cited by 64
Self-citationSmad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells
Müller, N., Reinacher‐Schick, A., Baldus, S. E., van Hengel, J., Berx, G., Baar, A., Roy, F. M. V., Schmiegel, W., & Schwarte‐Waldhoff, I. (2002) · Oncogene · doi:10.1038/sj.onc.1205766 · Cited by 65
Blagosklonny, M. V. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.6.1818 · Cited by 66
A role for cadherins in cellular signaling and differentiation
Knudsen, K. A., Frankowski, C., Johnson, K. R., & Wheelock, M. J. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+ · Cited by 88
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential
D’souza, N., Burns, J. S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, M. S., Horwitz, E. M., Paolucci, P., Conte, P., & Dominici, M. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_150 · Cited by 63
Semba, S., Kodama, Y., Ohnuma, K., Mizuuchi, E., Masuda, R., Yashiro, M., Hirakawa, K., & Yokozaki, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605309 · Cited by 62
Prime, S. S., Davies, M., Pring, M., & Paterson, I. C. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500603 · Cited by 63
Yu, Q., & Stamenkovic, I. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000037705.25256.d3 · Cited by 62
Wong, C. E., Yu, J. S., Quigley, D. A., To, M. D., Jen, K., Huang, P., Rosario, R. D., & Balmain, A. (2013) · Genes & Development · doi:10.1101/gad.210427.112 · Cited by 62
Self-citationThe Potential Influence of Radiation-Induced Microenvironments in Neoplastic Progression
Barcellos‐Hoff, M. H. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018794806635 · Cited by 60
Hypoxia-activated Smad3-specific Dephosphorylation by PP2A
Heikkinen, P. T., Nummela, M., Leivonen, S., Westermarck, J. K., Hill, C. S., Kähäri, V., & Jaakkola, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042978 · Cited by 64
Wang, J., Zhang, K., Grabowska, D., Li, A., Dong, Y., Day, R. B., Humphrey, P. A., Lewis, J. S., Kladney, R. D., Arbeit, J. M., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0241 · Cited by 61
Role of TGFβ in skin inflammation and carcinogenesis
Li, A. G., Lu, S., Han, G., Hoot, K. E., & Wang, X. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20229 · Cited by 61
Resveratrol Targets Transforming Growth Factor-β2 Signaling to Block UV-Induced Tumor Progression
Kim, K. H., Back, J. H., Zhu, Y., Arbesman, J., Athar, M., Kopelovich, L., Kim, A. L., & Bickers, D. R. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.250 · Cited by 59
Non-melanoma skin cancer in mouse and man
Schwarz, M., Münzel, P., & Braeuning, A. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0998-9 · Cited by 60
Quintanilla, M., Ramirez, J. R., Pérez-Gómez, E., Romero, D., Velasco, B., Letarte, M., López-Novoa, J. M., & Bernabéu, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206841 · Cited by 59
Shirley, S. H., Hudson, L. G., He, J., & Kusewitt, D. F. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20674 · Cited by 58
Han, C. L., Demetris, A. J., Liu, Y., Shelhamer, J. H., & Wu, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404852200 · Cited by 58
RetractedBiochemical markers in oncology. Part I: Molecular basis. Part II: Clinical uses
Voorzanger‐Rousselot, N., & Garnero, P. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.01.008 · Cited by 59
Rahimi, N., Tremblay, E., McAdam, L. C., Roberts, A. B., & Elliott, B. E. (1998) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-998-0023-z · Cited by 57
Mouse models for multistep tumorigenesis.
Wu, X.-M., & Pandolfi, P. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02127-4 · Cited by 70
So, P.-L., Lee, K. M. L., Hebert, J. L., Walker, P., Lü, Y., Hwang, J., Kopelovich, L., Athar, M., Bickers, D. R., Aszterbaum, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1927 · Cited by 57
Doi, H., Shibata, M., Kiyokane, K., & Otsuki, Y. (2003) · Journal of Dermatological Science · doi:10.1016/s0923-1811(03)00107-5 · Cited by 56
Sheng, H., Shao, J., O'Mahony, C. A., Lamps, L. W., Albo, D., Isakson, P. C., Berger, D. H., DuBois, R. N., & Beauchamp, R. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202397 · Cited by 56
Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection
Tunçbilek, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.6226 · Cited by 55
Rehman, A., Ali, S., Lone, M. A., Atif, M., Hassona, Y. M., Prime, S. S., Pitiyage, G. N., James, E. L., & Parkinson, E. K. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12370 · Cited by 57
Role of TGF-β in cancer and the potential for therapy and prevention
Kaklamani, V., & Pasche, B. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.4.649 · Cited by 57
Santibanez, J. F. (2013) · ISRN Dermatology · doi:10.1155/2013/597927 · Cited by 53
Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers
Glick, A. B., & Yuspa, S. H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.08.008 · Cited by 53
Danielpour, D. (2024) · Pharmaceuticals · doi:10.3390/ph17040533 · Cited by 58
PAI-1 Mediates the TGF-β1+EGF-Induced “Scatter” Response in Transformed Human Keratinocytes
Freytag, J., Wilkins-Port, C. E., Higgins, C. E., Higgins, S. P., Samarakoon, R., & Higgins, P. J. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.106 · Cited by 53
The concomitant apoptosis and EMT underlie the fundamental functions of TGF-β
Song, J., & Shi, W. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx117 · Cited by 51
A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
Pérez-Gómez, E., Villa‐Morales, M., Santos, J., Fernández‐Piqueras, J., Gamallo, C., Dotor, J., Bernabéu, C., & Quintanilla, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1348 · Cited by 52
Macho‐Maschler, S., Grünert, S., Danielopol, A., Beug, H., & Wirl, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207403 · Cited by 51
Systems genetics analysis of cancer susceptibility: from mouse models to humans
Quigley, D. A., & Balmain, A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2617 · Cited by 48
Self-citationPathological Relevance of Epithelial and Mesenchymal Phenotype Plasticity
Guarino, M., Micheli, P., Pallotti, F., & Giordano, F. (1999) · Pathology - Research and Practice · doi:10.1016/s0344-0338(99)80011-9 · Cited by 49
The transforming growth factor-β signaling pathway in tumorigenesis
Wieser, R. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200101000-00014 · Cited by 49
Pro‐metastasis function of TGFβ mediated by the smad pathway
Kang, Y. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20928 · Cited by 49
Biphasic role of TGF‐β1 in signal transduction and crosstalk
Wenner, C. E., & Yan, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10243 · Cited by 48
TGFβ1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line
Yi, J. Y., Hur, K. C., Lee, E., Jin, Y. J., Arteaga, C. L., & Son, Y. S. (2002) · European Journal of Cell Biology · doi:10.1078/0171-9335-00265 · Cited by 47
Tumor-suppressive and promoting function of transforming growth factor beta
Sun, L. (2004) · Frontiers in bioscience · doi:10.2741/1382 · Cited by 46
Evidence That Smad2 Is a Tumor Suppressor Implicated in the Control of Cellular Invasion
Prunier, C., Mazars, A., Noë, V., Bruyneel, E. A., Mareel, M. M. K., Gespach, C. P., & Atfi, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22919 · Cited by 47
Santibanez, J. F., Krstić, J., Fabra, À., Cano, A., & Quintanilla, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.042 · Cited by 46
Wach, S., Schirmacher, P., Protschka, M., & Blessing, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204962 · Cited by 46
Metadata
- Authors
- Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J.
- Affiliations
- University of Glasgow (GB)
- Corresponding author
- Akhurst, Rosemary J
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 86
- Issue
- 4
- Pages
- 531-542
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2026460094
- Cited by
- 628
- References
- 98
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 10 · 2023: 20 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 15 · 2014: 22 · 2013: 22 · 2012: 26
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- TGF-β1, skin carcinogenesis, sarcomatoid carcinoma, keratinocytes, tumor suppressor, malignant progression, TGF-beta3, epithelial-mesenchymal transition, chemical carcinogenesis, transgenic mice, epithelial cell plasticity
- MeSH terms
- Animals, Carcinoma, Carcinoma, Squamous Cell, Cells, Cultured, Female, Immunologic Techniques, Keratins, Mice, Transgenic, Papilloma, Skin Neoplasms, Integrins, Transforming Growth Factor beta, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
